Mustang Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells. The company is currently developing its proprietary Chimeric Antigen Receptor (CAR) engineered T cells technology which is licensed from Dr. Stephen Forman's laboratory at the City of Hope National Medical Center (COH). Through a research agreement with COH, the company will develop CARs across multiple cancers, including for AML and Brain Cancer.